Nasdaq

Roche to launch SARS-CoV-2 & Flu A/B Rapid Antigen Test in countries accepting the CE Mark to enable rapid differentiation of viral respiratory infections

Basel, 6 December 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced its plans to launch the SARS-CoV-2 & Flu A/B Rapid Antigen Test for professional use in markets accepting the CE Mark by the ...
Nasdaq

Roche to introduce its next-generation portfolio of SARS-CoV-2 rapid antigen tests ("2.0") under CE Mark for self-test and professional use

Broad and trusted portfolio of COVID-19 rapid tests feature innovative updates and enhanced performance, building on insights gained throughout the pandemic All tests now work seamlessly with navify® ...
FierceBiotech

Roche rebrands rapid COVID test as it heads to US store shelves

The FDA first issued an emergency authorization for the 20-minute test in December 2021. It will now be stocked at CVS Pharmacy locations nationwide. (Roche) U.S. consumers may already be familiar ...
The Indianapolis Star

Is it COVID, the flu, or RSV? A Roche test could soon provide the answer in 20 minutes

This past winter, hospitals and clinics across Indiana filled up with patients suffering from different respiratory illnesses that have much the same symptoms: COVID-19, flu and RSV. And many more ...